Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Wynton Hoover
Professor
Close
E-mail
whoover@uab.edu
Links
Provider Directory
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Wynton Hoover
Professor
Positions
Associate Scientist (C)
,
Cystic Fibrosis Research Center
,
School of Medicine
Professor (P)
,
Pediatric - Pulmonary & Sleep Medicine
,
Pediatrics
Publications
Research
Teaching
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2022
Application of lung volume reduction surgery for a child with filamin A (FLNA) mutations
.
Pediatric pulmonology. Supplement
. 57:224-230.
2022
2021
Noninvasive oscillometry to measure pulmonary mechanics in preterm infants
.
American Journal of Respiratory and Critical Care Medicine
. 204:485-488.
2021
2020
Dupilumab for chronic eosinophilic pneumonia
.
Pediatric pulmonology. Supplement
. 55:3229-3230.
2020
2019
Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study
2019
2019
Area deprivation as a risk factor for methicillin-resistant Staphylococcus aureus infection in pediatric cystic fibrosis
2019
2019
Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial
2019
2017
Effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first year of life
.
JAMA Pediatrics
. 171:546-554.
2017
2017
Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial
.
Thorax
. 72:318-326.
2017
2016
Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening
.
Pediatric pulmonology. Supplement
. 51:1168-1176.
2016
2015
Thymic hyperplasia and chylothorax
.
Pediatric pulmonology. Supplement
. 50:E37-E39.
2015
2015
Outcomes and treatment of chronic methicillin-resistant Staphylococcus aureus differs by staphylococcal cassette chromosome mec (SCCmec) type in children with cystic fibrosis
.
Journal of the Pediatric Infectious Diseases Society
. 4:225-231.
2015
2015
Multicenter observational study on factors and outcomes associated with various methicillin-resistant Staphylococcus aureus types in children with cystic fibrosis
.
Annals of the American Thoracic Society
. 12:864-871.
2015
2012
Clearance of initial mucoid Pseudomonas aeruginosa in patients with cystic fibrosis
.
Pediatric pulmonology. Supplement
. 47:1113-1122.
2012
2012
Inhibition of p21 activated kinase (PAK) reduces airway responsiveness in vivo and in vitro in murine and human airways
.
PLoS One
. 7.
2012
2011
Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3a4 inhibitor
.
Annals of Pharmacotherapy
. 45.
2011
2011
Targeting early events in cystic fibrosis disease pathogenesis
.
Drugs of the Future
. 36:133-140.
2011
2010
Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax
.
American Journal of Respiratory and Critical Care Medicine
. 182:298-306.
2010
2008
The congenital porto-caval fistula: A unique presentation and novel intervention
.
Pediatric pulmonology. Supplement
. 43:196-199.
2008
2007
Development of pulmonary hypertension in an infant treated with diazoxide
.
Journal of Pediatric Endocrinology and Metabolism
. 20:939-944.
2007
Chapter
Filter
Year
Title
Altmetric
2016
Restoration of CFTR function with small-molecule modulators
. 406-423.
2016
Research
Principal Investigator On
Baby Observational and Nutritional Study (BONUS-IP-11)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Characterization and Impact of MRSA Infection/Colonization in CF
awarded by
University of North Carolina at Chapel Hill
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (STAR-too - Ttaph Aureus Staph aureus Resistance - Treat or Observe)
awarded by
University of North Carolina at Chapel Hill
First Year Clinical Fellowship
awarded by
Cystic Fibrosis Foundation ^
First and Second Year Clinical Fellowship
awarded by
Cystic Fibrosis Foundation ^
Infant Study of Inhaled Saline (ISIS)
awarded by
University of North Carolina at Chapel Hill
Pediatric Physical Therapist Award
awarded by
Cystic Fibrosis Foundation ^
Prevalence and Significance of Staphylococcus Aureus Small–Colony Variants
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Private Grant
awarded by
INSPIRE PHARMACEUTICALS, INC
Private Grant
awarded by
Gilead Sciences ^
Saline Hypertonic in Preschoolers (SHIP)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Second Year Clinical Fellowship
awarded by
Cystic Fibrosis Foundation ^
TRI-STAR Initial and Chronic MRSA Infection in CF
awarded by
University of North Carolina at Chapel Hill
UAB Pediatric Pulmonary Center
awarded by
Health Resources and Services Administration/DHHS
Investigator On
A Multi-Center Study of a New Method of Sweat Testing: The CF Quantum Sweat Test
awarded by
University of Wisconsin-Madison
First/Second Year Clinical Fellowship
awarded by
Cystic Fibrosis Foundation ^
Functional Anatomic Imaging of CF Patients with Early Lung Disease Using microOCT
awarded by
National Heart, Lung, and Blood Institute/NIH/DHHS
G551D Observational Study-Expanded to Additional Genotypes and Extended for Long Term Follow-Up (GOAL-e2)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
PCD Foundation (PCDF) Registry: A Longitudinal Study of Patients with Primary Ciliary Dyskinesia
awarded by
THE PCD/KS FOUNDATION DBA PCD FOUNDATION
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients with Cystic Fibrosis
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
N30 PHARMACEUTICALS, LLC
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
N30 PHARMACEUTICALS, LLC
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PROQR THERAPEUTICS
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
CELTAXSYS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PTC THERAPEUTICS, INC.
Private Grant
awarded by
PARION SCIENCES, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
Proof of Principal Evaluation of IV Gallium Nitrate (Ganite) in Patients with Cystic Fibrosis
awarded by
SEATTLE CHILDREN'S HOSPITAL
The EPIC Observational Study: Longitudinal Assessment of Risk Factors for and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children with CF
awarded by
CHILDREN'S HOSPITAL & REGIONAL MEDICAL CENTER
Training and Equipment for the MBW sub-study of the PROSPECT Study.
awarded by
Cystic Fibrosis Foundation ^
Translational Therapeutic Development Center
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Pediatric Pulmonary Center
awarded by
Health Resources and Services Administration/DHHS
UAB Pediatric Pulmonary Center
awarded by
Health Resources and Services Administration/DHHS
UAB Therapeutic Development Network Center
awarded by
Cystic Fibrosis Foundation ^
Teaching
Teaching Activities
52-413 - PEDIATRIC PULMONARY (Fall Term 2012)
52-413 - PEDIATRIC PULMONARY (Fall Term 2013)
52-413 - PEDIATRIC PULMONARY (Fall Term 2016)
52-413 - PEDIATRIC PULMONARY (Fall Term 2016)
52-413 - PEDIATRIC PULMONARY (Fall Term 2016)
52-413 - PEDIATRIC PULMONARY (Fall Term 2016)
52-413 - PEDIATRIC PULMONARY (Fall Term 2017)
52-413 - PEDIATRIC PULMONARY (Fall Term 2017)
52-413 - PEDIATRIC PULMONARY (Fall Term 2017)
52-413 - PEDIATRIC PULMONARY (Fall Term 2018)
52-413 - PEDIATRIC PULMONARY (Fall Term 2019)
52-413 - PEDIATRIC PULMONARY (Spring Term 2014)
52-413 - PEDIATRIC PULMONARY (Spring Term 2017)
52-413 - PEDIATRIC PULMONARY (Spring Term 2017)
52-413M - PEDIATRIC PULMONARY (Fall Term 2020)
52-413M - PEDIATRIC PULMONARY (Fall Term 2020)
52-413M - PEDIATRIC PULMONARY (Fall Term 2020)
52-413M - PEDIATRIC PULMONARY (Fall Term 2021)
52-413M - PEDIATRIC PULMONARY (Fall Term 2021)
52-413M - PEDIATRIC PULMONARY (Fall Term 2021)
52-413M - PEDIATRIC PULMONARY (Fall Term 2021)
52-413M - PEDIATRIC PULMONARY (Fall Term 2022)
52-413M - PEDIATRIC PULMONARY (Fall Term 2022)
52-413M - PEDIATRIC PULMONARY (Spring Term 2021)
52-413M - PEDIATRIC PULMONARY (Spring Term 2022)
52-413M - PEDIATRIC PULMONARY (Spring Term 2022)
52-413M - PEDIATRIC PULMONARY (Spring Term 2023)
Background
Education And Training
Sacred Heart Hospital, Internship
Sacred Heart Hospital, Residency
Indiana University Medical Center, Postdoctoral Fellowship
Doctor of Medicine in Pediatrics Residency Program,
Louisiana State University System : University of New Orleans
2000
Contact
Full Name
Wynton
Hoover